Page 266 - Young, black and stigmatised: how haematologists harm patients with sickle cell disease
Dr Stephen Hibbs and Dr Sonia Wolf
References
- Strouse J, Lobner K, Lanzkron S, Haywood C. NIH and National Foundation Expenditures For Sickle Cell Disease and Cystic Fibrosis Are Associated With Pubmed Publications and FDA Approvals. Blood. 2013;122:1739
- AlJuburi G, Laverty A, Green S, Phekoo K, Bell D, Majeed A. Socio-economic deprivation and risk of emergency readmission and inpatient mortality in people with sickle cell disease in England: Observational study. Journal of Public Health 2013;35(4):510–517.
- Shapiro BS, Benjamin LJ, Payne R, Heidrich G. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manag.1997;14(3):168–74
- Elander J, Lusher J, Bevan D, Telfer P, Burton B. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manag.